期刊文献+

阿尔茨海默病与路易体痴呆患者临床表现对比分析 被引量:8

A comparative analysis of clinical manifestations of Alzheimer's disease patients and Lewy body dementia patients
原文传递
导出
摘要 目的比较阿尔茨海默病(AD)与路易体痴呆(DLB)患者的认知、精神行为症状等,为临床鉴别诊断提供证据。方法选取AD患者215例(AD组),DLB患者66例(DLB组),对两组患者的一般资料及家族史,疾病史进行回顾性分析,应用简易精神状态检查量表(MMSE)评定两组患者的认知能力,应用神经精神症状量表(NPI)评定两组患者常见痴呆精神行为症状。结果AD组合并高血压者多于DLB组;AD组113例(52.6%),DLB组24例(40%),P〈0.05。DLB组总体认知能力以及定向力、即刻回忆、延迟回忆方面优于AD组。DLB组波动性认知障碍、帕金森样症状较AD组突出。波动性认知障碍AD组2例(0.9%),DLB组19例(28.8%)(χ^2=8.580,P=0.003),帕金森样症状AD组26例(12.1%),DLB组25例(37.9%)(χ^2=22.602,P=0.000)。精神行为症状分析,NPI总分比较、幻觉及睡眠夜间行为异常DLB组较AD组常见。AD组幻觉32例(14.9%),夜间行为异常64例(29.8%),DLB组幻觉30例(46.2%),夜间行为异常30例(46.2%),P〈0.05。结论AD患者多合并高血压。DLB患者波动性认知障碍、帕金森样症状、幻觉、睡眠夜间行为异常为其常见突出表现。 ObjectiveTo compare cognitive, behavioral, and psychological symptoms observed in Alzheimer′s disease(AD)and dementia with Lewy body(DLB)in order to provide helpful information for differential diagnosis.MethodsWe selected 215 patients with AD(AD group)and 66 patients with DLB(DLB group)to retrospectively analyzed their general information, family history, and disease history.The Mini-Mental State Examination(MMSE scale)was used to evaluate cognitive abilities and Neuropsychiatric Inventory(NPI scale)was used for analysis of behavioral and psychological symptoms of dementia in both groups.ResultsThe prevalence of hypertension was higher in the AD group(52.6%, n=113)than in the DLB group(40%, n=24)(P〈0.05). The DLB group showed better general cognitive scores, disorientation scores, immediate recall scores, and delayed recall scores than the AD group.Fluctuating cognitive deficiencies and Parkinson′s symptoms were more prevalent in the DLB group than in the AD group with 2 patients(0.9%)showing fluctuating cognitive deficiencies in the AD group, and 19(28.8%)in the DLB group(χ^2=8.580, P=0.003); with 26 patients(12.1%)showing Parkinson′s symptoms in the AD group and 25(37.9%)in the DLB group(χ^2=22.602, P=0.000). As to behavioral and psychological symptoms, the DLB group had higher scores in total NPI, hallucinations and nighttime abnormal behaviors with 32 patients(14.9%)showing hallucinations and 64(29.8%)showing nighttime abnormal behaviors in the AD group; 30(46.2%)showing hallucinations and 30(46.2%)showing nighttime abnormal behaviors in the DLB group(all P〈0.05).ConclusionsHypertension is more prevalent in AD patients.Fluctuating cognitive deficiencies, Parkinson′s symptoms, hallucinations, and nighttime abnormal behaviors are prominent manifestations in DLB patients.
作者 徐俊英 刘帅 石志鸿 胡文政 甘景环 赵玉瑾 纪勇 Xu Junying;Liu Shuai;Shi Zhihong;Hu Wenzheng;Gan Jinghuan;Zhao Yujin;Ji Yong(Department of Neurology,Baodi Clinical College of Tianjin Medical University, Tianjin , 301800 China;Department of Neurology, Tianjin Huanhu Hospital, Tianjin, 300060 Chin;Graduate School of Tianjin Medical University, 300070 Tianjin ,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2018年第6期636-640,共5页 Chinese Journal of Geriatrics
关键词 阿尔茨海默病 路易体痴呆 认知能力 Alzheimer's disease Dementia with Lewy body Cognitive ability
  • 相关文献

参考文献3

二级参考文献19

  • 1Jia JP, Liu JH. The progress of pathogenesis and treatment of Alzheimer's disease. Chinese Journal of Contemporary Neurology and Neurosurgery, 2010, 10:43-48.
  • 2Johnson KA, Fox NC, Sperling RA, et al. Brain imaging in Alzheirner disease. Cold Spring Harb Perspect Med, 2012,2:a006213.
  • 3McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer' s disease: recommendations from the National Institute on Aging-Alzheimer' s Association workgroups on diagnostic guidelines for Alzheimer' s disease. Alzheimers Dement, 2011,7:263 269.
  • 4Korf ES, Wahlund LO, Visser PJ, et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology, 2004,63 : 94-100.
  • 5ManolioTA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke,1994, 25:318-327.
  • 6JiaJ, Sun B, Guo Z, et al. Positron emission tomography with Pittsburgh compound B in diagnosis of early stage Alzheimer' sdisease. Cell Biochem Biophys ,2011,59 : 57-62.
  • 7Mosconi L, Tsui WH, Herh01z K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med, 2008 49:390- 398.
  • 8Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol,2004, 55:306-319.
  • 9Kadir A, Almkvist O, Forsberg A, et al. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer' s disease. Neurobiol Aging, 2012,33:1- 14.
  • 10Engler H, Santillo AF, Wang SX, et al. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging, 2008,35: 100-106.

共引文献18

同被引文献79

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部